Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
18 May, 2026, 10.31 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
13 Apr, 2026, 11.14 PM IST
- Buy GlaxoSmithKline Consumer Healthcare, target Rs 7,310: Sharekhan
Buy GlaxoSmithKline Consumer Healthcare Ltd. at a price target of Rs 7310.0 .
21 Feb, 2018, 08.01 AM IST
- Accumulate GlaxoSmithKline Consumer Healthcare, target Rs 6,797: Prabhudas Lilladher
Accumulate GlaxoSmithKline Consumer Healthcare Ltd. at a price target of Rs 6797.0 .
15 Feb, 2018, 08.02 AM IST
- Buy GlaxoSmithKline Consumer Healthcare, target Rs 6765 : ICICI Securities
Buy GlaxoSmithKline Consumer Healthcare Ltd. at a price target of Rs 6765. The stock has been trading at 25 times its FY18 earnings multipl...
03 Jan, 2017, 02.35 PM IST
- Buy GlaxosmithKline Consumer Healthcare with a target of Rs 6,430: Sandeep Wagle
"GlaxosmithKline Consumer Healthcare is a 'BUY' call with a target of Rs 6,430 and a stop loss of Rs 6,070. "
09 Dec, 2015, 08.17 AM IST
- Buy GSK Consumer Healthcare Ltd with a target of Rs 5490: Sandeep Wagle
"GSK Consumer Healthcare Ltd is a 'BUY' call with a target of Rs 5490 and a stop loss of Rs 5085."
27 Aug, 2014, 09.11 AM IST
GlaxoSmithKline Consumer Healthcare Ltd India-Novartis deal won't affect business in IndiaGlaxoSmithKline Consumer Healthcare today said the global deal between GlaxoSmithKline Plc and Novartis won't affect its business in India.
22 Apr, 2014, 05.44 PM IST
NSE to drop GlaxoSmithKline Consumer from F&O segmentNSE said it will exclude GlaxoSmithKline Consumer Healthcare from the Futures and Options segment with effect from May 30.
20 Mar, 2014, 08.43 PM IST
GlaxoSmithKline Consumer expands Horlicks portfolioHorlicks Kesar Badaam is the fourth variant in the Horlicks portfolio; the other flavours available are Malt, Chocolate and Elaichi.
17 Jan, 2014, 08.39 PM IST
- GlaxoSmithKline Plc's open offer for GSKCH to start on January 17
The UK-based GlaxoSmithKline Plc's open offer to acquire 31.8 per cent stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare w...
04 Dec, 2012, 09.32 PM IST
- GlaxoSmithKline Consumer Healthcare to focus on breakfast and snack segments
GlaxoSmithKline Consumer Healthcare (GSKCH) is planning to focus on the breakfast and snack segment as its next growth drivers in India.
14 May, 2012, 09.28 PM IST
- GSK re-enters oral care market with Sensodyne
Sensodyne, GSK's biggest global brand with an annual sales of $750 million, has close to a 10% share of the US toothpaste market.
06 Jan, 2011, 05.49 AM IST
- GSK to invest Rs 300 crore in Horlicks relaunch
Packaged consumer goods company GlaxoSmithKline Consumer Healthcare (GSKCH) said it would invest over Rs 300 crore on repositioning origina...
14 Sep, 2010, 12.59 AM IST
- GSK Consumer Healthcare net up 30 pc at Rs 71.75 cr
GlaxoSmithKline Consumer Healthcare Ltd reported a 30 per cent jump in net profit for the quarter ended June 30, 2010 at Rs 71.75 crore fro...
02 Aug, 2010, 07.56 PM IST
- GSK profit up 15%, to pay Rs 18 per share
In a filing to BSE, the company also declared a final dividend of Rs 18 per share of face value of Rs 10.
24 Apr, 2010, 03.07 AM IST